CHASE KEIRN: Open Payments
NPI 1902328909 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 10 payments from 2 companies in 2025. Trend: 2023 $99 · 2024 $762 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $259 |
| GlaxoSmithKline, LLC. | 5 | $137 |
Products named: NUCALA, FASENRA, BREZTRI, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
